Related references
Note: Only part of the references are listed.IL-33 biology in cancer: An update and future perspectives
Wen Jie Yeoh et al.
CYTOKINE (2022)
Metabolism and immunity in breast cancer
Deyu Zhang et al.
FRONTIERS OF MEDICINE (2021)
canSAR: update to the cancer translational research and drug discovery knowledgebase
Costas Mitsopoulos et al.
NUCLEIC ACIDS RESEARCH (2021)
Prevalence of Molecular Subtypes of Breast Carcinoma and Its Comparison between Two Different Age Groups: A Retrospective Study from a Tertiary Care Center of Northeast India
Jagannath Dev Sharma et al.
SOUTH ASIAN JOURNAL OF CANCER (2021)
Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review
Sergiusz Lukasiewicz et al.
CANCERS (2021)
The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape
Mi-Ran Choi et al.
CANCERS (2021)
Prognostic and predictive parameters in breast pathology: a pathologist's primer
Kimberly H. Allison
MODERN PATHOLOGY (2021)
Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis
Isabel dos-Santos-Silva et al.
LANCET GLOBAL HEALTH (2019)
IL-33 increases ST2(+) Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner
E. C. Halvorsen et al.
ONCOIMMUNOLOGY (2019)
Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer
Armando E. Giuliano et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
Atif Ali Hashmi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Interleukin-33 in Malignancies: Friends or Foes?
Jia-Xin Shen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Serum IL-33 level is a predictor of progression-free survival after chemotherapy
Wenwei Hu et al.
ONCOTARGET (2017)
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Marie-Helene Wasmer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study
Xi Zeng et al.
DISEASE MARKERS (2016)
Circulating IL-33 level is associated with the progression of lung cancer
Myung Shin Kim et al.
LUNG CANCER (2015)
Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
J. Y. Kim et al.
ONCOGENE (2015)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Survival of patients with metastatic breast cancer according to pathological types of tumors
Cesar Sanchez R et al.
REVISTA MEDICA DE CHILE (2014)
Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases
Qing Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer
Qingli Bie et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Significance of interleukin-33 and its relatec cytokines in patients with breast cancers
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immune approaches to the treatment of breast cancer, around the corner?
Carmen Criscitiello et al.
BREAST CANCER RESEARCH (2014)
Significance of immunohistochemistry in breast cancer
Dana Carmen Zaha
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Pilar Eroles et al.
CANCER TREATMENT REVIEWS (2012)
Detection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications
P. Zhang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
IL-33/ST2 axis in innate and acquired immunity to tumors
Ivan P. Jovanovic et al.
ONCOIMMUNOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
The multiple roles of amphiregulin in human cancer
Benoit Busser et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Sylvain Ladoire et al.
JOURNAL OF PATHOLOGY (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2010)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Share Paper
